A,acute bronchiolitis,259
A,acute gastroenteritis,567
A,acute otitis media,458,703
A,acute respiratory distress syndrome,541
A,acute respiratory failure,162
A,adhesion molecule,630
A,adult,150
A,Aeromonas hydrophila,155
A,aggR,134
A,AIDS,984
A,allogeneic bone marrow transplantation,365
A,amantadine,6,476,699
A,amantadine resistance,646
A,amebiasis,57
A,amebic colitis,552
A,amebic liver abscess,585
A,American Thoracic Society guideline,43
A,amphotericin B,365
A,antiadherent material,431
A,antibiotic resistance,1
A,antibody,670
A,antibody response,30
A,antigenic analysis,481
A,anti-HIV agent,237
A,antimicrobial activity,441
A,antimicrobial material,431
A,antiviral naive,128
A,aseptic meningitis,231
A,aspergillosis,536
A,astA,134
A,ATP,120
A,auto-antibody,811
B,bacteremia,51
B,bacterial meningitis,339,811
B,Bartonella henselae,387,563
B,BCG,245
B,biotype,96
B,borderline personality disorder,1077
B,bronchoalveolar lavage（BAL）,675
C,C7 deficiency,720
C,Campylobacter fetus subspecies fetus,269
C,Capnocytophaga,594
C,cat,824
C,cat scratch disease,387,563
C,cavitary isolation of tubercle bacilli,245
C,cerebrospinal fluid,811
C,chemokine receptor,237
C,chickenpox,670
C,children,6,12,339,458,699
C,Chlamydia pneumoniae,954,1018
C,Chlamydia psittaci,954
C,Chlamydia trachomatis,37
C,chronic pulmonary tuberculosis,245
C,chronic respiratory tract infection,846
C,cicatricial stricture,552
C,clinical laboratory automation,501
C,CMV-antigenemia,215
C,coccidioidomycosis,580
C,codon 215,360
C,combination therapy,128
C,community-acquired pneumonia,43
C,conjugative R plasmid,816
C,consensus primer,470
C,continuous ambulatory peritoneal dialysis,73
C,Crimean-Congo hemorrhagic fever,87
C,cryptosporidiosis,518
C,Cryptosporidium parvum,518
C,culture negative endocarditis,51
C,cytokine,573,630
C,cytomegalovirus（CMV）,215,675,828
D,dental calculus,961
D,diabetes mellitus,486
D,diabetic neuropathy,486
D,diarrheagenic Escherichia coli,372
D,disinfectant,664,1023
D,disseminated intravascular coagulation,541
D,domestic case,834
D,drug,966
D,drug resistance,128,237,331,345,450,511,834,1004
D,drug susceptibility,96,816
D,DTwP vaccine,150
E,eaeA,134
E,Ebola hemorrhagic fever,87
E,echovirus 30,231
E,elderly,17,30,43,353,476
E,electrolyzed functioning water,120
E,emphysematous cystitis,486
E,Entamoeba histolytica,585
E,enteropathogenic Escherichia coli,134
E,enzyme immunoassay,563,841,1032,1038
E,enzyme-linked fluorescent assay,709
E,epidemiology,64,104,458,653
E,Epstein-Barr virus,828
E,Escherichia coli,24,250,339
E,Escherichia coli O157,527
E,Etest<SUP>(R)</SUP>,221
E,experimental model,441
E,extended-spectrum β-lactamase（ESBL）,24,112,250
F,falciparum malaria,491
F,familial infection,104
F,febrile episode,353
F,fecal flora,365
F,fluconazole,365
F,fluoroquinolone,345
F,fosfomycin,1004
F,fungal infection,365
G,gastrointestinal infection,57
G,gene analysis,481
G,genotype,450,470
G,genotypic assay,128
H,Haemophilus aphrophilus,1081
H,Haemophilus influenzae,339
H,HCV,961
H,heart transplantation,378
H,Helicobacter pylori,120,601
H,hematological disease,215
H,hemodialysis,73
H,hemolysin gene,155
H,hemolytic activity,155
H,hemolytic anemia,724
H,hemolytic streptococci,511
H,hemophagocytic syndrome,630
H,hepatitis,828
H,hepatitis A,716
H,hetero-resistant,966
H,heterogeneously resistant,653
H,highly active antiretroviral therapy,638
H,HIV,82
H,HIV infection,57,1077
H,HIV p24 antigen,709
H,HIV-1,128,237,360,450,638
H,hospital infection,465
H,human herpes virus-6,264
H,hypoxemia,259
I,IgG antibody,387
I,IgM antibody,387
I,IL-10,598
I,immunization,30
I,immunocompetent host,594
I,immunomagnetic separation,527
I,immunosuppressant,378
I,imported case,834
I,imported mycosis,580
I,indirect fluorescence antibody,387
I,infant,458,675
I,infection control system,501
I,infectious disease control,687
I,infectious enteritis,816
I,infectious mononucleosis-like syndrome,264
I,infective endocarditis,51
I,influenza,476,646,699,1032
I,influenza A virus,6,841
I,influenza B virus,481
I,influenza vaccine,17,30
I,influenza virus,12,949,973,1038
I,influenza virus infection,1044,1062
I,intelligent database,501
I,interleukin 8,811
I,intracellular enzyme activity,73
J,Japanese spotted fever,162,278
K,Klebsiella pneumoniae,24
L,Lassa fever,87
L,law,687
L,lecithin,431,441
L,Legionnaires' disease,989
L,line sepsis,96
L,liver biopsy,984
L,liver transplantation,378
L,lower respiratory tract infection,274
L,lung abscess,594
L,lung cancer,536
L,lymphoid tumor,215
M,macrolide,846
M,macrophage,598
M,malaria,694
M,malnutrition,331
M,Marburg disease,87
M,maximum biosafety level ward,87
M,measles,670
M,medical student,465
M,men who have sex with men（MSM）,716
M,meningococcemia,720
M,metabolic acidosis,491
M,MIC,221,601
M,microdilution method,221
M,microorganism,846
M,miliary tuberculosis,541
M,minocycline,598
M,mixed infection,949
M,morphology,1018
M,MRSA,573,653,658,966
M,Mu3 agar,653
M,multiple organ failure,989
M,mumps,670
M,Mycobacterium,64
M,Mycobacterium avium-intracellulare complex（MAC）,64
M,Mycoplasma pneumoniae,259,954
N,nalidixic acid,345
N,nasal aspirate,1032
N,necrosis,536
N,neonatal exanthematous disease,573
N,neonate,392
N,neuraminidase,12
N,neuraminidase inhibitor,1044,1062
N,neutrophil dysfunction,73
N,Nocardia farcinica,274
N,nontuberculous mycobacteriosis,274
N,Norwalk-like virus,470,567
N,nosocomial infection,353
N,nursing home,476,646
N,nursing home-acquired pneumonia,331
O,Orientia tsutsugamushi,598
O,oseltamivir phosphate,1044,1062
O,O-sero-group,155,372
O,outbreak,278
O,outbreak of dysentery,1004
O,oxidative burst,73
P,pacemaker,980
P,PCR,24,250,372,392,675,984
P,PCR-restriction fragment length polymorphism,646
P,pediatrics,694
P,pelvic inflammatory disease,269
P,penicillin-resistant Streptococcus pneumoniae（PRSP）,458,658,703
P,penicillin intermediate resistant Streptococcus pneumoniae,658
P,pest,87
P,phenotype,450
P,plasmid,24
P,plasmid profile,816,104
P,pneumonia,547
P,polymicrobial infection,331
P,prevalence,511
P,primary infection,360
P,primary tuberculosis,245
P,Proteus mirabilis,250
P,proton pump inhibitor,601
P,pulsed-field gel electrophoresis（PFGE）,1,96,104,143
P,pyogenic vertebral osteomyelitis,1081
R,radiograph,954
R,rapid diagnosis,12,841,1032,1038
R,re-emerging infectious disease,580
R,respiratory tract infection,949
R,rhabdomyolysis,989
R,RS virus,949
R,RT-PCR,82,567
R,rubella,670,724,1012
S,saliva,961
S,Salmonella,345,816
S,Salmonella paratyphi A,143
S,Salmonella typhi,143
S,salpingitis,269
S,scaling,961
S,screening test,82
S,serotyping,511
S,serovar,37,64
S,serum antibody,150
S,sexually transmitted disease,57
S,Shiga toxin-producing Escherichia coli（STEC）,104
S,Shigella,834
S,Shigella sonnei,1004
S,shock,720
S,SHV-12 Escherichia coli,112
S,side effect,30
S,silver citrate,431,441
S,solid-organ transplantation,378
S,species and serovar,834
S,sporadic diarrhea,155
S,Staphylococcus aureus,966
S,Staphylococcus epidermidis,96
S,Staphylococcus schleiferi,980
S,steroid therapy,162
S,streptococcal pyrogenic exotoxin,511
S,Streptococcus agalactiae,339
S,Streptococcus pneumoniae,1,339,547
S,stridor,675
S,superantigen,573
S,surrogate marker,638
S,surveillance,973
S,susceptibility,966
S,systemic aspergillosis,378
S,systemic infection,1
T,TNF-α,598
T,Toho-1,250
T,toxic shock syndrome toxin-1（TSST-1）,573
T,Toxocara cati,824
T,tuberculosis,465,984
T,tuberculous peritonitis,589
T,tympanostomy tube,703
U,ultrasonography-guided needle biopsy,589
U,urethral catheter,431,441
U,urinary antibody,1012
U,urinary antigen,547
U,uterine cervix,37
V,vaccination,465,1012
V,vaccine efficacy,17
V,vancomycin,966
V,vancomycin-resistant Staphylococcus aureus,653
V,varicella-zoster virus,392
V,verotoxin,849
V,verotoxin-producing Escherichia coli（VTEC）,849
V,viral infection,465
V,virucidal activity,664,1023
V,virus isolation,231,638
V,virus phenotype,638
W,waterborne outbreak,518
W,window period,709
Y,yeast,221
Z,zidovudine resistance,360